Significant Ownership of COLUMN GROUP II, LP

Signature - Title
/s/ James Evangelista, Attorney-in-Fact - James Evangelista, Attorney-in-Fact
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by COLUMN GROUP II, LP.

Notify me when COLUMN GROUP II, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of COLUMN GROUP II, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value 4.9% $1,395,126 1,603,593 Peter Svennilson 23 Dec 2024
ORIC ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 3.7% $48,612,534 3,644,118 Peter Svennilson 30 Sep 2025

Schedules 13D/G Reported by COLUMN GROUP II, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.